DE3485773D1 - Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten. - Google Patents

Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.

Info

Publication number
DE3485773D1
DE3485773D1 DE8484113229T DE3485773T DE3485773D1 DE 3485773 D1 DE3485773 D1 DE 3485773D1 DE 8484113229 T DE8484113229 T DE 8484113229T DE 3485773 T DE3485773 T DE 3485773T DE 3485773 D1 DE3485773 D1 DE 3485773D1
Authority
DE
Germany
Prior art keywords
degenerative diseases
cells
mesenchym
cultivated
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484113229T
Other languages
English (en)
Other versions
DE3485773T2 (de
Inventor
Ralph Silverman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3485773D1 publication Critical patent/DE3485773D1/de
Publication of DE3485773T2 publication Critical patent/DE3485773T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8484113229T 1983-11-04 1984-11-05 Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten. Expired - Fee Related DE3485773T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54925783A 1983-11-04 1983-11-04

Publications (2)

Publication Number Publication Date
DE3485773D1 true DE3485773D1 (de) 1992-07-23
DE3485773T2 DE3485773T2 (de) 1993-02-11

Family

ID=24192255

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484113229T Expired - Fee Related DE3485773T2 (de) 1983-11-04 1984-11-05 Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.

Country Status (4)

Country Link
EP (1) EP0142109B1 (de)
JP (1) JPS6133124A (de)
AT (1) ATE77241T1 (de)
DE (1) DE3485773T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63130537A (ja) * 1986-11-19 1988-06-02 Ichimaru Pharcos Co Ltd プラセンタ−由来生理活性物質含有皮膚用剤
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) * 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor

Also Published As

Publication number Publication date
ATE77241T1 (de) 1992-07-15
EP0142109A3 (en) 1987-01-21
EP0142109A2 (de) 1985-05-22
JPS6133124A (ja) 1986-02-17
DE3485773T2 (de) 1993-02-11
EP0142109B1 (de) 1992-06-17

Similar Documents

Publication Publication Date Title
ATE169820T1 (de) Verwendung eines bakteriziden/die permeabilität erhöhenden proteins oder von biologisch aktiven analogen davon zur herstellung eines arzneimittels zur behandlung von endotoxin- assoziierten storungen
ATE100858T1 (de) Pflanzengewebe-transformation.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE68913962T2 (de) Bioreaktor und vorrichtung zur kultivierung von tierischen zellen.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
DE3280479T2 (de) Rekombinante DNS-Mittel und Verfahren
DE3888642T2 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
DE3484416D1 (de) Intraalveolare vorrichtung zur verabreichung von wirkstoffen zum behandeln periodontaler krankheiten.
DE3678900D1 (de) Vorrichtung zur kontinuierlichen behandlung von viskosem material.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE3681144D1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
ATE242316T1 (de) Neurale transplantation durch verwendung von pluripotenten neuroepithelzellen
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
AR004093A1 (es) El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas.
DE3485773D1 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
FR2634103B1 (fr) Procede et produit permettant l'elimination des insectes nuisibles et accelerant le developpement des plantes traitees
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE3872160D1 (de) Morpholinylsilane und verwendung zur beherrschung von pflanzenkrankheiten, verursacht durch pilze.
AT383142B (de) Vorrichtung zur kultivierung und behandlung von biokatalysatoren
FR2529213B1 (fr) Derive keratinique, son procede de preparation et composition de traitement le contenant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee